Cocktail party: Low-dose antibody combinations deliver pan-ebolavirus protection.

Anthony, Scott M; Hensley, Lisa E

Anthony, Scott M; Hensley, Lisa E.

Anthony SM; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA. Electronic address: scott.anthony@nih.gov.
Hensley LE; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Frederick, MD 21702, USA. Electronic address: lisa.hensley@nih.gov.

Cell ; 185(6): 943-945, 2022 03 17.

Article en En | MEDLINE | ID: mdl-35303426

ABSTRACT

ABSTRACT

Recent outbreaks of Ebola have brought to the forefront the need for focused therapeutic treatments. In this issue of Cell, Milligan and colleagues build on previous studies of antibody treatments for Ebola virus disease, uncovering broad synergistic protective immunity when administered in combination (as antibody cocktails).

Asunto(s)

Ebolavirus; Fiebre Hemorrágica Ebola; Anticuerpos Monoclonales/inmunología; Anticuerpos Neutralizantes/inmunología; Anticuerpos Neutralizantes/uso terapéutico; Anticuerpos Antivirales/inmunología; Anticuerpos Antivirales/uso terapéutico; Ebolavirus/inmunología; Epítopos/inmunología; Fiebre Hemorrágica Ebola/tratamiento farmacológico; Fiebre Hemorrágica Ebola/inmunología; Fiebre Hemorrágica Ebola/prevención & control; Humanos

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Ebolavirus Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article